Pfizer (NYSE:PFE) Announces Promising Phase 3 Results For Breast Cancer Therapy Vepdegestrant
Pfizer (NYSE:PFE) announced positive outcomes from the Phase 3 VERITAC-2 clinical trial, showing vepdegestrant's promise in treating advanced breast cancer, which could be a significant driver of the ...
Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings
Even though Pfizer Inc.'s ( NYSE:PFE ) recent earnings release was robust, the market didn't seem to notice. We ...
Pfizer, Arvinas post mixed late-stage trial results for breast cancer therapy (update)
Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant ...
Is Pfizer Inc. (PFE) the Best Pharma Stock to Buy According to Hedge Funds?
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Rep. Jefferson Shreve Purchases Shares of Pfizer Inc. (NYSE:PFE)
Representative Jefferson Shreve (R-Indiana) recently bought shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March ...
Pfizer's Direct-To-Consumer Model Faces Scrutiny From US Senators (CORRECTED)
This article has been corrected to reflect that the senators asked UpScriptHealth to respond. In August 2024, Pfizer Inc ...
Moderna suffers setback in vaccine patent battle with Pfizer
Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
Pfizer boosts anti-obesity efforts: adds former J&J exec. as chief internal medicine officer
Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...
The Pharma Letter3d
Pfizer lures former J&J exec to be its CIMO
US pharma giant Pfizer (NYSE: PFE) today announced that James List, has joined the company as chief internal medicine officer ...
ETF Daily News5d
Sen. John Boozman Sells Off Shares of Pfizer Inc. (NYSE:PFE)
Pfizer (NYSE:PFE – Get Free Report) last released its quarterly earnings results on Tuesday, February 4th.The biopharmaceutical company reported $0.63 earnings per share for the quarter, beating ...